Abstract
Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in children and young adults. It is responsible of a broad array of extrapulmonary manifestations, the most severe affecting the central nervous system. We report a challenging diagnosis of macrolide-resistant M. pneumoniae-induced Bickerstaff encephalitis in a 16-year-old man.
Keywords:
Bickerstaff encephalitis; Immunomodulators; Macrolide resistance; Mycoplasma pneumoniae.
Copyright © 2024 Elsevier Inc. All rights reserved.
MeSH terms
-
Adolescent
-
Anti-Bacterial Agents / therapeutic use
-
Community-Acquired Infections / diagnosis
-
Community-Acquired Infections / epidemiology
-
Community-Acquired Infections / microbiology
-
Disease Outbreaks
-
Drug Resistance, Bacterial
-
Encephalitis* / diagnosis
-
Encephalitis* / microbiology
-
Humans
-
Macrolides / therapeutic use
-
Male
-
Mycoplasma pneumoniae* / genetics
-
Mycoplasma pneumoniae* / isolation & purification
-
Pneumonia, Mycoplasma* / diagnosis
-
Pneumonia, Mycoplasma* / drug therapy
-
Pneumonia, Mycoplasma* / epidemiology
-
Pneumonia, Mycoplasma* / microbiology
Substances
-
Anti-Bacterial Agents
-
Macrolides